1. Retinoblastoma Protein Expression and Prognosis in Laryngeal Cancer
- Author
-
Shuran Ma, Masaru Ohyama, Kazuyoshi Ueno, Yoshito Eizuru, Fumiko Dokiya, and Shigeru Furuta
- Subjects
Adult ,Male ,Pathology ,medicine.medical_specialty ,Retinoblastoma Protein ,Metastasis ,medicine ,Carcinoma ,Humans ,Laryngeal Neoplasms ,Survival rate ,Lymph node ,Aged ,Neoplasm Staging ,Aged, 80 and over ,biology ,Retinoblastoma ,business.industry ,Retinoblastoma protein ,Cancer ,General Medicine ,Middle Aged ,Prognosis ,medicine.disease ,Immunohistochemistry ,Gene Expression Regulation, Neoplastic ,medicine.anatomical_structure ,Otorhinolaryngology ,Epidermoid carcinoma ,Lymphatic Metastasis ,Carcinoma, Squamous Cell ,biology.protein ,Female ,business ,Carcinoma in Situ - Abstract
Expression of retinoblastoma (Rb) protein was immunohistochemically examined in laryngeal squamous cell neoplasias from 72 patients. Staining patterns were considered with reference to such prognostic factors as patient's age, histologic grade, tumour size and lymph node status, and 5-year survival rate. Rb protein negativity, either partial or complete, was noted in 28.8% of cases and was associated with a significantly lower 5-year survival rate, as well as with a higher likelihood of lymph node metastasis. This suggests that Rb alteration may be a prognostic indicator in patients with laryngeal carcinoma.
- Published
- 1998
- Full Text
- View/download PDF